Pricing Log in Create free account

IDEAYA Biosciences, Inc. (IDYA) vs Viking Therapeutics, Inc. (VKTX)

IDEAYA Biosciences, Inc. and Viking Therapeutics, Inc. are both Biotechnology companies. IDEAYA Biosciences, Inc. and Viking Therapeutics, Inc. are of similar size ($3.5B and $3.3B). Viking Therapeutics, Inc. has the higher net margin (0.00% vs −74.8%) and the higher return on invested capital (0.00% vs −36.7%). Across the 13 metrics below, IDEAYA Biosciences, Inc. leads on 8 and Viking Therapeutics, Inc. on 5.

Valuation

Metric IDYA VKTX Biotechnology median
P/E n/m n/m 8.50
P/S 12.92 n/m 9.71
P/B 2.52 7.17 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 9.38 n/m 9.21
Earnings yield (5.84%) (18.51%) (33.15%)
Free cash flow yield (3.77%) (14.30%) (25.50%)

Profitability

Metric IDYA VKTX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (92.66%) 0.00% 0.00%
Net margin (74.75%) 0.00% 0.00%
Free cash flow margin (48.64%) 0.00% 0.00%
Return on equity (16.22%) (88.85%) (56.36%)
Return on assets (14.89%) (79.24%) (48.04%)
Return on invested capital (36.65%) 0.00% 0.00%

Growth

Metric IDYA VKTX Biotechnology median
Revenue growth (TTM) 901.18% — 6.02%
EPS growth (last fiscal year) 61.90% (215.84%) 30.26%
Revenue growth, 5-year CAGR 62.11% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IDYA VKTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.45 4.72 4.72
Net debt to EBITDA 3.88 1.76 0.96

Dividend

Metric IDYA VKTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IDYA VKTX Biotechnology median
Market cap 3.27b 3.48b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack